Call us now:
Poor computer security may have been the reason an acquirer pulled out of the $4.3billion acquisition of Akorn, a generic drugs maker. Exposing wider questions around the provinonce of data.
View Original Post
https://www.linkedin.com/feed/update/urn%3Ali%3Ashare%3A6422702673971286016
